NO330951B1 - Fremgangsmate for a fremstille produkter inneholdende antihypertensive tripeptider og produkter inneholdende disse - Google Patents

Fremgangsmate for a fremstille produkter inneholdende antihypertensive tripeptider og produkter inneholdende disse

Info

Publication number
NO330951B1
NO330951B1 NO20022061A NO20022061A NO330951B1 NO 330951 B1 NO330951 B1 NO 330951B1 NO 20022061 A NO20022061 A NO 20022061A NO 20022061 A NO20022061 A NO 20022061A NO 330951 B1 NO330951 B1 NO 330951B1
Authority
NO
Norway
Prior art keywords
products containing
preparing
tripeptides
product
antihypertensive tripeptides
Prior art date
Application number
NO20022061A
Other languages
English (en)
Norwegian (no)
Other versions
NO20022061L (no
NO20022061D0 (no
Inventor
Annika Mayra-Makinen
Olli Tossavainen
Tarja Suomalainen
Janne Sahlstein
Original Assignee
Valio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valio Ltd filed Critical Valio Ltd
Publication of NO20022061D0 publication Critical patent/NO20022061D0/no
Publication of NO20022061L publication Critical patent/NO20022061L/no
Publication of NO330951B1 publication Critical patent/NO330951B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/14Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/142Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
    • A23C9/1427Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration by dialysis, reverse osmosis or hyperfiltration, e.g. for concentrating or desalting
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00Working-up of proteins for foodstuffs
    • A23J3/30Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/341Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
    • A23J3/343Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
    • A23J3/344Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins of casein
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • A23L2/66Proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/147Helveticus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Water Supply & Treatment (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
NO20022061A 1999-11-01 2002-04-30 Fremgangsmate for a fremstille produkter inneholdende antihypertensive tripeptider og produkter inneholdende disse NO330951B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI992360A FI113741B (fi) 1999-11-01 1999-11-01 Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi
PCT/FI2000/000942 WO2001032905A1 (en) 1999-11-01 2000-10-30 Process for producing a product containing antihypertensive tripeptides

Publications (3)

Publication Number Publication Date
NO20022061D0 NO20022061D0 (no) 2002-04-30
NO20022061L NO20022061L (no) 2002-06-28
NO330951B1 true NO330951B1 (no) 2011-08-22

Family

ID=8555541

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20022061A NO330951B1 (no) 1999-11-01 2002-04-30 Fremgangsmate for a fremstille produkter inneholdende antihypertensive tripeptider og produkter inneholdende disse
NO20022062A NO20022062L (no) 1999-11-01 2002-04-30 Lactobacillus helveticus som produserer antihypertensive di- og tripeptider

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20022062A NO20022062L (no) 1999-11-01 2002-04-30 Lactobacillus helveticus som produserer antihypertensive di- og tripeptider

Country Status (23)

Country Link
US (2) US6972282B1 (zh)
EP (2) EP1226267B1 (zh)
JP (2) JP4172681B2 (zh)
KR (2) KR100718709B1 (zh)
CN (2) CN1197956C (zh)
AT (2) ATE285470T1 (zh)
AU (2) AU769432B2 (zh)
CA (2) CA2388354A1 (zh)
CZ (2) CZ294146B6 (zh)
DE (2) DE60016959T2 (zh)
DK (2) DK1226267T3 (zh)
EE (2) EE05461B1 (zh)
ES (2) ES2220557T3 (zh)
FI (1) FI113741B (zh)
HR (2) HRP20020378B1 (zh)
HU (2) HUP0203185A3 (zh)
NO (2) NO330951B1 (zh)
NZ (2) NZ518470A (zh)
PL (2) PL364790A1 (zh)
PT (2) PT1226267E (zh)
RU (2) RU2270855C2 (zh)
WO (2) WO2001032905A1 (zh)
ZA (2) ZA200203179B (zh)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI113741B (fi) * 1999-11-01 2004-06-15 Valio Oy Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi
FI112031B (fi) 2002-02-25 2003-10-31 Valio Oy Biologisesti aktiivisen tuotteen uusi käyttö
EP1509609B1 (en) 2002-06-04 2015-04-22 DSM IP Assets B.V. Protein hydrolysate rich in tripeptides
CN100451127C (zh) * 2002-08-09 2009-01-14 科·汉森有限公司 制备具有抗高血压特性的肽的方法
PL378232A1 (pl) * 2003-01-06 2006-03-20 Unilever N.V. Fermentowany produkt mleczny, zawierający tripeptydy VPP i/albo IPP
TWI344371B (en) * 2003-03-18 2011-07-01 Suntory Holdings Ltd Angiotensin-converting enzyme inhibitory peptides
US7718171B2 (en) 2003-04-07 2010-05-18 Chr. Hansen A/S Reducing heart rate in mammals using milk derived fermentation products produced using Lactobacillus helveticus
JP2006525003A (ja) * 2003-05-05 2006-11-09 ユニリーバー・ナームローゼ・ベンノートシヤープ Ippおよび/またはvppを含む加水分解カゼイン製品
JP2007529206A (ja) * 2004-03-19 2007-10-25 カンピーナ ネーダーランド ホールディング ビー.ブイ. アンジオテンシン−i−変換酵素阻害特性を有する食品成分及び食品の調製方法、並びにその方法により得られる製品
WO2005094848A1 (ja) * 2004-03-31 2005-10-13 Calpis Co., Ltd. 肝障害予防又は抑制剤及び肝障害予防又は抑制用機能性食品
US7862808B2 (en) 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
WO2006004105A1 (ja) * 2004-07-05 2006-01-12 Calpis Co., Ltd. ペプチド混合物の製造法、抗高血圧ペプチド含有発酵乳の製造法及び抗高血圧ペプチド製剤の製造法
BRPI0513237A (pt) * 2004-07-12 2008-04-29 Dsm Assets B V hidrolisados de proteìna para diminuição de pressão sanguìnea
EP1685764A1 (en) 2005-01-27 2006-08-02 Globus Egg Sciences B.V. Anti-hypertensive functional food products
ATE532416T1 (de) 2004-09-03 2011-11-15 Chr Hansen As Fermentierte milchproteine mit rezeptor-ligand und ihre verwendungen
FR2876874B1 (fr) * 2004-10-22 2007-02-16 Gervais Danone Sa Protection d'ingredients alimentaires bioactifs par l'utilisation d'ingredients leurres
FR2876876B1 (fr) * 2004-10-22 2007-02-16 Gervais Danone Sa Protection d'ingredients alimentaires bioactifs par l'utilisation de microorganismes presentant une capacite de metabolisation reduite
EP1827477B1 (en) * 2004-12-22 2015-10-21 DSM IP Assets B.V. Blood pressure lowering oligopeptides in a single enzymatic step
EP1879465A1 (en) * 2005-02-09 2008-01-23 Unilever N.V. Composition comprising peptide
WO2006089921A1 (en) * 2005-02-24 2006-08-31 Dsm Ip Assets B.V. Blood pressure lowering peptides from glycomacropeptide
US7303745B2 (en) 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
CN101316928B (zh) 2005-11-28 2014-12-10 帝斯曼知识产权资产管理有限公司 产生清洁味道的酶制剂
US20090299036A1 (en) * 2006-02-14 2009-12-03 Calpis Co, Ltd Agent for preventing arteriosclerosis, agent for suppressing vascular intimal thickening and agent for improving vascular endothelial function
BRPI0707827A2 (pt) * 2006-02-14 2011-05-10 Calpis Co Ltd vasodilatador
ATE423840T1 (de) * 2006-02-20 2009-03-15 Gervais Danone Sa Neue stämme von lactobacillus helveticus
DE602006004956D1 (de) * 2006-02-20 2009-03-12 Gervais Danone Sa Neue Stämme von Lactobacillus helveticus
PL1820851T3 (pl) * 2006-02-20 2012-07-31 Gervais Danone Sa Szczepy Lactobacillus helveticus nie fermentujące laktozy
CN100370019C (zh) * 2006-04-21 2008-02-20 江南大学 一种具有抗高血压作用的植物乳杆菌cw006
RU2457852C2 (ru) * 2006-05-15 2012-08-10 Валио Лтд Новое применение терапевтически эффективных пептидов
US20090111758A1 (en) * 2006-05-15 2009-04-30 Valio Ltd. Use of therapeutically useful peptides
CN101678051B (zh) * 2006-09-04 2012-12-12 雪印惠乳业株式会社 促进血中脂连蛋白浓度增加及/或抑制其减少的制剂及内脏脂肪蓄积抑制剂
PT1915913E (pt) * 2006-10-23 2016-02-16 Nestec Sa Modulação do sabor e do aroma de produtos lácteos por biotransformação
EP1952703B1 (de) * 2007-02-02 2010-08-25 May, Amadeus Alexander Produkt mit lebenden probiotischen Mikroorganismen
US10842813B2 (en) 2007-02-26 2020-11-24 Heartbeet Ltd Compositions of nitrates and methods of use thereof
US11759477B2 (en) 2007-02-26 2023-09-19 Heartbeet Ltd. Compositions of nitrates and methods of use thereof
JP5292633B2 (ja) * 2007-03-27 2013-09-18 カルピス株式会社 腎不全予防剤
JP2011524744A (ja) * 2008-06-12 2011-09-08 ネステク ソシエテ アノニム 降圧ペプチドを産生するためのラクトバチルス・ヘルベティカス株
DE102008032828A1 (de) 2008-07-02 2010-01-07 Technische Universität Dresden Tryptophanhaltige Peptide aus alpha-Lactalbumin mit blutdrucksenkender und vasoprotektiver Wirkung für biofunktionelle Lebensmittel
FI122531B (fi) * 2009-09-30 2012-03-15 Valio Oy Juusto ja menetelmä sen valmistamiseksi
RU2453593C1 (ru) * 2011-04-21 2012-06-20 Общество с ограниченной ответственностью "Бифилюкс" Штамм lactobacillus helveticus, используемый для получения продукции, содержащей лактобактерии
CN102786580A (zh) * 2012-07-17 2012-11-21 上海交通大学 抗高血压活性肽ivp
CN102786579B (zh) * 2012-07-17 2014-07-09 上海交通大学 抗高血压活性肽vip
RU2580052C1 (ru) * 2014-12-24 2016-04-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Горский государственный аграрный университет" Штамм lactobacillus helveticus вкпм в-11176, полученный на доступных питательных средах
RU2577112C1 (ru) * 2014-12-25 2016-03-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Горский государственный аграрный университет" Штамм lactobacillus helveticus вкпм в-11175, полученный на доступных питательных средах
CA3043392A1 (en) 2016-12-02 2018-06-07 Fairlife, Llc Non-browning lactose-free milk powder and methods of making same
RU2685912C1 (ru) * 2018-03-14 2019-04-23 Федеральное государственное автономное научное учреждение "Научно-исследовательский институт хлебопекарной промышленности" Штамм бактерий lactobacillus amylolyticus, используемый для приготовления термофильной заквашенной заварки
RU2728171C2 (ru) * 2018-11-08 2020-07-28 Общество с ограниченной ответственностью "Инновационные биотехнологии" (ООО "Инбиотех") Штамм бактерий Lactobacillus helveticus T-5068, используемый в качестве закваски прямого внесения для приготовления кисломолочных продуктов
CN109517763B (zh) * 2018-12-27 2022-03-22 内蒙古农业大学 瑞士乳杆菌h11及其应用
TWI713972B (zh) * 2019-01-14 2020-12-21 大江生醫股份有限公司 改善呼吸道健康之益生菌株及其組合物與用途
AU2021247419A1 (en) * 2020-04-02 2022-11-03 Fatah Bashir AHTESH Milk fermentation process
CN112029784A (zh) * 2020-09-16 2020-12-04 内蒙古农业大学 一个与蛋白水解能力相关的基因及基于该基因的高蛋白水解能力瑞士乳杆菌的筛选方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2483748A1 (fr) * 1980-06-06 1981-12-11 Corning Glass Works Procede d'hydrolyse du lactose contenu dans les lactoserums a l'aide de lactase immobilisee
JPS6153216A (ja) 1984-08-23 1986-03-17 Rikagaku Kenkyusho 高血圧症予防治療剤
JP2782142B2 (ja) * 1992-07-23 1998-07-30 カルピス株式会社 アンジオテンシン変換酵素阻害剤及びその製造法
JP2782153B2 (ja) * 1992-11-09 1998-07-30 カルピス株式会社 アンジオテンシン変換酵素阻害ペプチドの製造法
JP2824821B2 (ja) 1993-11-04 1998-11-18 カルピス株式会社 乳酸菌及び発酵乳製品
GB2294191B (en) 1994-10-06 1997-10-01 Waterford Creamery Ltd Cheese manufacture
JP3782837B2 (ja) * 1995-04-10 2006-06-07 カルピス株式会社 血圧降下剤及びその製造法
JPH09188694A (ja) 1996-01-10 1997-07-22 Otsuka Shokuhin Kk ペプチド、アンジオテンシン変換酵素阻害組成物及びその製法
JP3746556B2 (ja) 1996-02-09 2006-02-15 カルピス株式会社 プラスミド及びプラスミドベクター
US5854029A (en) 1996-08-02 1998-12-29 Calpis Co., Ltd. Method for preparing antihypertensive agent
JP4727770B2 (ja) * 1997-09-26 2011-07-20 カルピス株式会社 尿中カテコールアミン低下、尿中ノルアドレナリン低下、尿中ドーパミン低下及びFischer比低下の少なくとも1つの軽減剤
JP3028411B2 (ja) * 1997-09-26 2000-04-04 カルピス株式会社 トリペプチド高生産性ラクトバチルス・ヘルベチカス乳酸菌
FI104783B (fi) * 1998-02-12 2000-04-14 Valio Oy Herasuolajauhe, menetelmä sen valmistamiseksi ja sen käyttö
FI113741B (fi) * 1999-11-01 2004-06-15 Valio Oy Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi
US6514941B1 (en) * 1999-12-10 2003-02-04 Campina Melkunie B.V. Method of preparing a casein hydrolysate enriched in anti-hypertensive peptides

Also Published As

Publication number Publication date
CN1387577A (zh) 2002-12-25
CN1387564A (zh) 2002-12-25
EP1226267A1 (en) 2002-07-31
KR100718709B1 (ko) 2007-05-16
DE60016959T2 (de) 2005-12-22
PT1226267E (pt) 2004-08-31
CN1164761C (zh) 2004-09-01
HU226200B1 (en) 2008-06-30
EP1226230A1 (en) 2002-07-31
US6890529B1 (en) 2005-05-10
AU777795B2 (en) 2004-10-28
FI113741B (fi) 2004-06-15
KR100704441B1 (ko) 2007-04-24
HRP20020377A2 (en) 2003-08-31
ES2220557T3 (es) 2004-12-16
KR20020064895A (ko) 2002-08-10
NO20022061L (no) 2002-06-28
JP3695648B2 (ja) 2005-09-14
WO2001032836A1 (en) 2001-05-10
PL364790A1 (en) 2004-12-13
ES2234686T3 (es) 2005-07-01
EE05461B1 (et) 2011-08-15
EP1226230B1 (en) 2004-12-22
NZ518470A (en) 2003-03-28
RU2276689C2 (ru) 2006-05-20
HRP20020378A2 (en) 2003-08-31
DK1226230T3 (da) 2005-04-04
RU2270855C2 (ru) 2006-02-27
JP2003513636A (ja) 2003-04-15
PL204119B1 (pl) 2009-12-31
ZA200203172B (en) 2003-09-23
EE200200230A (et) 2003-06-16
US6972282B1 (en) 2005-12-06
AU769432B2 (en) 2004-01-29
HUP0203185A2 (hu) 2003-01-28
CA2387738A1 (en) 2001-05-10
CA2387738C (en) 2008-09-16
JP2003513621A (ja) 2003-04-15
CZ302271B6 (cs) 2011-01-19
ATE285470T1 (de) 2005-01-15
EE200200231A (xx) 2003-06-16
DE60010742D1 (de) 2004-06-17
DK1226267T3 (da) 2004-09-20
CZ20021369A3 (cs) 2002-07-17
NO20022062L (no) 2002-06-28
NZ518493A (en) 2003-03-28
PT1226230E (pt) 2005-04-29
CZ20021431A3 (cs) 2002-08-14
JP4172681B2 (ja) 2008-10-29
AU1149901A (en) 2001-05-14
DE60010742T2 (de) 2005-05-12
HUP0203185A3 (en) 2005-07-28
CN1197956C (zh) 2005-04-20
DE60016959D1 (de) 2005-01-27
EP1226267B1 (en) 2004-05-12
HUP0203256A3 (en) 2005-11-28
AU1149801A (en) 2001-05-14
WO2001032905A1 (en) 2001-05-10
HUP0203256A2 (hu) 2003-01-28
HRP20020377B1 (en) 2005-06-30
KR20020060220A (ko) 2002-07-16
NO20022062D0 (no) 2002-04-30
HRP20020378B1 (en) 2005-06-30
CA2388354A1 (en) 2001-05-10
NO20022061D0 (no) 2002-04-30
CZ294146B6 (cs) 2004-10-13
ZA200203179B (en) 2003-07-22
PL355670A1 (en) 2004-05-04
FI19992360A (fi) 2001-05-02
ATE266735T1 (de) 2004-05-15

Similar Documents

Publication Publication Date Title
NO330951B1 (no) Fremgangsmate for a fremstille produkter inneholdende antihypertensive tripeptider og produkter inneholdende disse
DE60327422D1 (de) Verfahren zur stabilisierung von ubichinol in lebensmitteln
DK1455603T3 (da) Stimulering af in vivo produktion af proteiner med en formulering, der omfatter leucin
DK0973408T3 (da) Spiseis med bløde tilsætninger
PL358431A1 (en) Cultured protein hydrolysate
FI970518A (fi) Majoneesin tapainen tuote ja menetelmä sen valmistamiseksi
DE69105654D1 (de) Protein-Dispersionen in Nahrungsmitteln.
DE69831420D1 (de) Herstellung von nahrungsmitteln durch fermentierung von sojamilch mit streptococcus thermophilus
DK1366674T3 (da) Levnedsmiddeladditiv
TW200633645A (en) Increase in the protein proportion of animal organisms
ATE376361T1 (de) Fermentiertes, sojaproteine enthaltendes lebensmittel

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees